Literature DB >> 27324126

Regulation of fibronectin gene expression in cardiac fibroblasts by scleraxis.

Rushita A Bagchi1,2,3, Justin Lin1, Ryan Wang1, Michael P Czubryt4,5.   

Abstract

The glycoprotein fibronectin is a key component of the extracellular matrix. By interacting with numerous matrix and cell surface proteins, fibronectin plays important roles in cell adhesion, migration and intracellular signaling. Up-regulation of fibronectin occurs in tissue fibrosis, and previous studies have identified the pro-fibrotic factor TGFβ as an inducer of fibronectin expression, although the mechanism responsible remains unknown. We have previously shown that a key downstream effector of TGFβ signaling in cardiac fibroblasts is the transcription factor scleraxis, which in turn regulates the expression of a wide variety of extracellular matrix genes. We noted that fibronectin expression tracked closely with scleraxis expression, but it was unclear whether scleraxis directly regulated the fibronectin gene. Here, we report that scleraxis acts via two E-box binding sites in the proximal human fibronectin promoter to govern fibronectin expression, with the second E-box being both sufficient and necessary for scleraxis-mediated fibronectin expression to occur. A combination of electrophoretic mobility shift and chromatin immunoprecipitation assays indicated that scleraxis interacted to a greater degree with the second E-box. Over-expression or knockdown of scleraxis resulted in increased or decreased fibronectin expression, respectively, and scleraxis null mice presented with dramatically decreased immunolabeling for fibronectin in cardiac tissue sections compared to wild-type controls. Furthermore, scleraxis was required for TGFβ-induced fibronectin expression: TGFβ lost its ability to induce fibronectin expression following scleraxis knockdown. Together, these results demonstrate a novel and required role for scleraxis in the regulation of cardiac fibroblast fibronectin gene expression basally or in response to TGFβ.

Entities:  

Keywords:  Extracellular matrix; Gene expression; Gene regulation; Promoter; Transcription

Mesh:

Substances:

Year:  2016        PMID: 27324126     DOI: 10.1007/s00441-016-2439-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  15 in total

Review 1.  Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.

Authors:  Yuanjun Guo; Manisha Gupte; Prachi Umbarkar; Anand Prakash Singh; Jennifer Y Sui; Thomas Force; Hind Lal
Journal:  J Mol Cell Cardiol       Date:  2017-07-27       Impact factor: 5.000

Review 2.  Defining the Cardiac Fibroblast.

Authors:  Malina J Ivey; Michelle D Tallquist
Journal:  Circ J       Date:  2016-10-14       Impact factor: 2.993

3.  Scleraxis lineage cells contribute to organized bridging tissue during tendon healing and identify a subpopulation of resident tendon cells.

Authors:  Katherine T Best; Alayna E Loiselle
Journal:  FASEB J       Date:  2019-04-05       Impact factor: 5.191

4.  Scleraxis is required for the growth of adult tendons in response to mechanical loading.

Authors:  Jonathan P Gumucio; Martin M Schonk; Yalda A Kharaz; Eithne Comerford; Christopher L Mendias
Journal:  JCI Insight       Date:  2020-07-09

5.  Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts.

Authors:  Meiling Melzer; David Beier; Pampee P Young; Sarika Saraswati
Journal:  J Vis Exp       Date:  2020-03-12       Impact factor: 1.355

Review 6.  RAS inhibition in resident fibroblast biology.

Authors:  Alexandra M Garvin; Bilal S Khokhar; Michael P Czubryt; Taben M Hale
Journal:  Cell Signal       Date:  2020-12-25       Impact factor: 4.315

Review 7.  3D bioprinting of cardiac tissue: current challenges and perspectives.

Authors:  Brian Kato; Gary Wisser; Devendra K Agrawal; Tim Wood; Finosh G Thankam
Journal:  J Mater Sci Mater Med       Date:  2021-05-06       Impact factor: 3.896

8.  Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart.

Authors:  Xing Fu; Hadi Khalil; Onur Kanisicak; Justin G Boyer; Ronald J Vagnozzi; Bryan D Maliken; Michelle A Sargent; Vikram Prasad; Iñigo Valiente-Alandi; Burns C Blaxall; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

9.  The Transcription Factor SCX is a Potential Serum Biomarker of Fibrotic Diseases.

Authors:  Miguel Ramírez-Aragón; Fernando Hernández-Sánchez; Tatiana S Rodríguez-Reyna; Ivette Buendía-Roldán; Gael Güitrón-Castillo; Carlos A Núñez-Alvarez; Diego F Hernández-Ramírez; Sergio A Benavides-Suárez; Alexia Esquinca-González; Ana Lilia Torres-Machorro; Criselda Mendoza-Milla
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 10.  Cardiac Fibroblast to Myofibroblast Phenotype Conversion-An Unexploited Therapeutic Target.

Authors:  Michael P Czubryt
Journal:  J Cardiovasc Dev Dis       Date:  2019-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.